Stock listing

DMRA Stock Price, News, Filings & Events — Damora Therapeutics, Inc.

Selected listing: DMRA · NASDAQ · USD · US

This page tracks Damora Therapeutics, Inc.'s DMRA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DMRA:NASDAQ. DMRA:NASDAQ is the stock-level entry point for investors researching Damora Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Damora Therapeutics, Inc. is a public company traded under the ticker DMRA in the American market. With a market capitalization of approximately $1.77 billion, the company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.

DMRA:NASDAQUSDUSUpdated September 5, 2026
Damora Therapeutics, Inc. logo
Ticker
DMRA:NASDAQ
Asset type
Stock
Market cap
$1.86B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Damora Therapeutics, Inc. DMRA:NASDAQ stock context

This page tracks Damora Therapeutics, Inc.'s DMRA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DMRA:NASDAQ. DMRA:NASDAQ is the stock-level entry point for investors researching Damora Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Damora Therapeutics, Inc. is a public company traded under the ticker DMRA in the American market. With a market capitalization of approximately $1.77 billion, the company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its strategic initiatives and research efforts.

Latest news from Damora Therapeutics, Inc.

All Damora Therapeutics, Inc. news →

Research Damora Therapeutics, Inc.

Alternate listings